Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEOSTIGMINE vs NEPAFENAC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEOSTIGMINE vs NEPAFENAC: Safety Overview

Metric NEOSTIGMINE NEPAFENAC
Total FAERS Reports 252 1,761
Deaths Reported 18 5
Death Rate 7.1% 0.3%
Hospitalizations 83 46
Average Patient Age 45.6 yrs 65.7 yrs
% Female Patients 55.1% 60.2%
FDA Approval Date N/A Aug 19, 2005
Manufacturer N/A Harrow Eye, LLC
Route N/A OPHTHALMIC
Marketing Status N/A Prescription